Michael G. Ison

16.0k total citations · 4 hit papers
234 papers, 8.5k citations indexed

About

Michael G. Ison is a scholar working on Epidemiology, Infectious Diseases and Transplantation. According to data from OpenAlex, Michael G. Ison has authored 234 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 162 papers in Epidemiology, 91 papers in Infectious Diseases and 37 papers in Transplantation. Recurrent topics in Michael G. Ison's work include Respiratory viral infections research (77 papers), Influenza Virus Research Studies (56 papers) and Cytomegalovirus and herpesvirus research (37 papers). Michael G. Ison is often cited by papers focused on Respiratory viral infections research (77 papers), Influenza Virus Research Studies (56 papers) and Cytomegalovirus and herpesvirus research (37 papers). Michael G. Ison collaborates with scholars based in United States, Canada and Australia. Michael G. Ison's co-authors include Frederick G. Hayden, Hannah Nam, Michael A. Nalesnik, Valentina Stosor, Cameron R. Wolfe, Michael Angarone, Marian G. Michaels, Michele I. Morris, Emily A. Blumberg and Paolo Grossi and has published in prestigious journals such as New England Journal of Medicine, JAMA and Nature Communications.

In The Last Decade

Michael G. Ison

223 papers receiving 8.3k citations

Hit Papers

Clinical Practice Guidelines by the Infectious Diseases S... 2018 2026 2020 2023 2018 2023 2019 2019 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa
    2018 492 citations Frederick G. Hayden, Michael G. Ison et al. profile →
  2. Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults
    2023 405 citations Michael G. Ison et al. profile →
  3. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa
    2019 229 citations Frederick G. Hayden, Michael G. Ison et al. profile →
  4. Respiratory syncytial virus infection in adults
    2019 205 citations Hannah Nam, Michael G. Ison profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael G. Ison United States 51 5.7k 2.9k 1.2k 920 906 234 8.5k
José María Aguado Spain 48 4.4k 0.8× 3.5k 1.2× 1.9k 1.5× 764 0.8× 831 0.9× 298 7.9k
Asunción Moreno Spain 51 5.6k 1.0× 3.9k 1.3× 1.3k 1.1× 951 1.0× 550 0.6× 257 8.2k
Deepali Kumar Canada 56 6.8k 1.2× 3.8k 1.3× 1.6k 1.4× 1.2k 1.3× 1.5k 1.7× 233 10.0k
Raymund R. Razonable United States 58 8.1k 1.4× 3.8k 1.3× 1.5k 1.3× 980 1.1× 2.3k 2.5× 290 11.1k
Nina Singh United States 54 8.1k 1.4× 5.9k 2.0× 1.5k 1.3× 701 0.8× 766 0.8× 162 10.5k
Emily A. Blumberg United States 44 4.5k 0.8× 2.0k 0.7× 1.3k 1.1× 1.6k 1.8× 983 1.1× 185 7.0k
Atul Humar Canada 67 10.6k 1.9× 4.1k 1.4× 2.2k 1.8× 1.6k 1.7× 2.9k 3.3× 275 14.4k
Shahid Husain Canada 54 6.6k 1.2× 5.2k 1.8× 2.3k 1.9× 818 0.9× 1.1k 1.2× 250 10.4k
Lindsey R. Baden United States 56 5.0k 0.9× 5.9k 2.0× 720 0.6× 345 0.4× 1.7k 1.9× 230 10.7k
André C. Kalil United States 44 5.0k 0.9× 2.3k 0.8× 719 0.6× 251 0.3× 498 0.5× 169 9.1k

Countries citing papers authored by Michael G. Ison

Since Specialization
Citations

This map shows the geographic impact of Michael G. Ison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael G. Ison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael G. Ison more than expected).

Fields of papers citing papers by Michael G. Ison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael G. Ison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael G. Ison. The network helps show where Michael G. Ison may publish in the future.

Co-authorship network of co-authors of Michael G. Ison

This figure shows the co-authorship network connecting the top 25 collaborators of Michael G. Ison. A scholar is included among the top collaborators of Michael G. Ison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael G. Ison. Michael G. Ison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heldman, Madeleine R., Michael Boeckh, & Michael G. Ison. (2025). Influenza Antivirals for Prevention and Treatment in Immunocompromised People. The Journal of Infectious Diseases. 232(Supplement_3). S243–S253. 3 indexed citations
2.
Post, Diane J., et al.. (2025). Collaborative influenza vaccine innovation centers (CIVICs) program. Vaccine. 54. 127118–127118. 1 indexed citations
3.
Lane, M. Chelsea, Catherine J. Luke, Joseph Bresee, et al.. (2024). Meeting Report: Controlled Human Influenza Virus Infection Model Studies: Current Status and Future Directions for Innovation. Influenza and Other Respiratory Viruses. 18(10). e13358–e13358. 1 indexed citations
4.
Blumberg, Emily A., Oliver Witzke, Michael G. Ison, et al.. (2024). Maribavir for refractory cytomegalovirus infection (with or without resistance) in solid organ transplant recipients: Subgroup analysis of the phase 3 randomized SOLSTICE study. The Journal of Heart and Lung Transplantation. 44(6). 986–994. 1 indexed citations
5.
Vinson, Amanda J., Ran Dai, Amy L. Olex, et al.. (2024). The prevalence of postacute sequelae of coronavirus disease 2019 in solid organ transplant recipients: Evaluation of risk in the National COVID Cohort Collaborative. American Journal of Transplantation. 24(9). 1675–1689. 1 indexed citations
6.
Simons, Lacy M., Ramón Lorenzo-Redondo, Nina L. Reiser, et al.. (2022). Assessment of Virological Contributions to COVID-19 Outcomes in a Longitudinal Cohort of Hospitalized Adults. Open Forum Infectious Diseases. 9(3). ofac027–ofac027. 9 indexed citations
7.
Ison, Michael G., et al.. (2022). Economic and clinical burden associated with respiratory viral infections after allogeneic hematopoietic cell transplant in the United States. Transplant Infectious Disease. 24(4). e13866–e13866. 3 indexed citations
8.
Demonbreun, Alexis R., Thomas W. McDade, Lorenzo L. Pesce, et al.. (2021). Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposure. JCI Insight. 6(9). 20 indexed citations
9.
Post, Lori Ann, Charles B. Moss, Robert L. Murphy, et al.. (2021). SARS-CoV-2 Wave Two Surveillance in East Asia and the Pacific: Longitudinal Trend Analysis. Journal of Medical Internet Research. 23(2). e25454–e25454. 21 indexed citations
10.
Post, Lori Ann, Charles B. Moss, Robert L. Murphy, et al.. (2021). Surveillance Metrics of SARS-CoV-2 Transmission in Central Asia: Longitudinal Trend Analysis. Journal of Medical Internet Research. 23(2). e25799–e25799. 13 indexed citations
11.
Kates, Olivia S., Peter G. Stock, Michael G. Ison, et al.. (2021). Ethical review of COVID-19 vaccination requirements for transplant center staff and patients. American Journal of Transplantation. 22(2). 371–380. 29 indexed citations
12.
Welch, Sarah B, P. V. Vara Prasad, Charles B. Moss, et al.. (2021). The Interplay Between Policy and COVID-19 Outbreaks in South Asia: Longitudinal Trend Analysis of Surveillance Data. JMIR Public Health and Surveillance. 7(6). e24251–e24251. 7 indexed citations
13.
Post, Lori Ann, Charles B. Moss, Robert L. Murphy, et al.. (2021). Surveillance of the Second Wave of COVID-19 in Europe: Longitudinal Trend Analyses. JMIR Public Health and Surveillance. 7(4). e25695–e25695. 26 indexed citations
14.
Post, Lori Ann, Michael J Boctor, Tariq Z. Issa, et al.. (2021). SARS-CoV-2 Surveillance System in Canada: Longitudinal Trend Analysis. JMIR Public Health and Surveillance. 7(5). e25753–e25753. 8 indexed citations
15.
Nam, Hannah & Michael G. Ison. (2020). 1496. Aspergillosis Complicating Severe Respiratory Syncytial Virus (RSV) in ICU Patients: A Retrospective Cohort Study. Open Forum Infectious Diseases. 7(Supplement_1). S750–S750. 3 indexed citations
16.
Lin, Adam Yuh, Michael J. Cuttica, Michael G. Ison, & Leo I. Gordon. (2020). Ibrutinib for chronic lymphocytic leukemia in the setting of respiratory failure from severe COVID‐19 infection: Case report and literature review. SHILAP Revista de lepidopterología. 1(2). 596–600. 18 indexed citations
17.
Post, Lori Ann, Charles B. Moss, Robert L. Murphy, et al.. (2020). SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis. Journal of Medical Internet Research. 23(1). e25830–e25830. 20 indexed citations
18.
Post, Lori Ann, Tariq Z. Issa, Michael J Boctor, et al.. (2020). Dynamic Public Health Surveillance to Track and Mitigate the US COVID-19 Epidemic: Longitudinal Trend Analysis Study. Journal of Medical Internet Research. 22(12). e24286–e24286. 27 indexed citations
19.
Theodoropoulos, Nicole, Andrés Jaramillo, Daniela P. Ladner, & Michael G. Ison. (2013). Deceased Organ Donor Screening for HIV, Hepatitis B, and Hepatitis C Viruses: A Survey of Organ Procurement Organization Practices. American Journal of Transplantation. 13(8). 2186–2190. 21 indexed citations
20.
Ison, Michael G. & Frederick G. Hayden. (2002). Viral infections in immunocompromised patients: whatʼs new with respiratory viruses?. Current Opinion in Infectious Diseases. 15(4). 355–367. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José María Aguado Breakdown of academic impact, for papers by Asunción Moreno Breakdown of academic impact, for papers by Deepali Kumar Breakdown of academic impact, for papers by Raymund R. Razonable Breakdown of academic impact, for papers by Nina Singh Breakdown of academic impact, for papers by Emily A. Blumberg Breakdown of academic impact, for papers by Atul Humar Breakdown of academic impact, for papers by Shahid Husain Breakdown of academic impact, for papers by Lindsey R. Baden Breakdown of academic impact, for papers by André C. Kalil
Rankless by CCL
2026